Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy

Prog Hemost Thromb. 1986:8:1-18.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Disease Models, Animal
  • Drug Synergism
  • Enzyme Activation
  • Fibrin / metabolism*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Injections, Intravenous
  • Kinetics
  • Plasminogen / metabolism
  • Plasminogen Activators / administration & dosage
  • Plasminogen Activators / pharmacology
  • Plasminogen Activators / therapeutic use*
  • Protein Conformation
  • Substrate Specificity
  • Thromboembolism / drug therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / pharmacology
  • Tissue Plasminogen Activator / therapeutic use*
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / pharmacology
  • Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Fibrin
  • Plasminogen
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator